GenoMed4All at ASH 2022 New Orleans
Last December some members from GenoMed4All's clinical team travelled all the way to New Orleans for the 64th Annual Meeting and Exposition of the American Society of Hematology.
GenoMed4All was featured there as a showcase of the work currently going on within our use cases. We had the opportunity to present a poster and present our research in an oral presentation. Take a look:
- The foundation of our oral presentation: Real-World Validation of Molecular International Prognostic Scoring System (IPSS-M) for Myelodysplastic Syndrome
- The full text making up our poster: Multi-Modal Analysis and Federated Learning Approach for Classification and Personalized Prognostic Assessment in Myeloid Neoplasms
And as a treat, scroll down to see our teammates from Humanitas just having a great time at ASH 2022!
GenoMed4All at the IUBMB Focused Meeting - Hemoglobin Switching Conference
This month has been a busy one! Early in May, GenoMed4All participated in the IUBMB Focused Meeting - Hemoglobin Switching Conference, a reference event for scientific exchange and dialogue on globin gene regulation and pathophysiology.
The Sickle Cell Disease (SCD) team proudly presented a poster showcasing the work done so far, titled: "GenoMed4All: Artificial Intelligence-based Deep Learning algorithms for patients with Sickle Cell Disease". Our colleague Petros Kountouris -from The Cyprus Institute of Neurology & Genetics- was there on behalf of the project and reports that there was a lot of interest from the participants in these specific results.
Congratulations to everyone involved! You can check out the poster here at our Zenodo repository.